Filters
Catalog peptides
Linker
Synthesis of unnatural amino acids and other blocks
Retatrutide
Name
Retatrutide
Molecular structural formula
Purity
≥98%
CAS Number
2381089-83-2
Formula
C221H342N46O68
MW
4731.33
Target
GCGR GLP Receptor
Sequence
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{diacid-C20-gamma-Glu-(AEEA)-Lys}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Sequence Shortening
Y-{Aib}-QGTFTSDYSI-{α-Me-Leu}-LDK-{diacid-C20-gamma-Glu-(AEEA)-Lys}AQ-{Aib}-AFIEYLLEGGPSSGAPPPS-NH2
Solubility in DMSO
50 mg/mL
Solubility in water
20 mg/mL
References
[1]. Tamer Coskun, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metab. 2022 Sep 6;34(9):1234-1247.e9.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Retatrutide is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide can be used for the research of obesity.